为什么要与澳门在线赌城娱乐合作?

We have a global strength, with balanced presence across regions and disease areas. 澳门第一赌城在线娱乐的创新药物, many of which are developed in partnership with others, are used by millions of patients worldwide.

首页 / 合作 /为什么与澳门在线赌城娱乐合作



$37.4bn

总营收

$876m

合作的收入

>75

major or strategically important business development transactions completed in last three years

>1,000

collaborations worldwide help us access the best science, stimulate innovation and accelerate delivery of new medicines for unmet medical needs

83,100

员工

28

manufacturing sites in 16 countries

$9.7bn

投资于澳门第一赌城在线娱乐的科学

90%

of pipeline incorporates a precision medicine approach


For year ending 31 December 2021
 


Pushing the boundaries of science to deliver life-changing medicines

Inspired by our values and what science can do, we are focused on accelerating the delivery of life-changing medicines that create enduring value for patients and society.



Encouraging innovation and inspiring the next generation of start-ups

Entrepreneurial thinking is one of our core values and at the heart of what we do. We are also passionate about supporting innovation in life sciences and helping the next generation of entrepreneurs succeed within our local bioscience ecosystems globally. 




Veeva ID: Z4-49876
Date of preparation: November 2022